|
Wagner, J A; Jarai, Z; Batkai, S et al. (2001) Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Eur J Pharmacol 423:203-10
|
|
Kunos, G; Jarai, Z; Varga, K et al. (2000) Cardiovascular effects of endocannabinoids--the plot thickens. Prostaglandins Other Lipid Mediat 61:71-84
|
|
Kunos, G; Jarai, Z; Batkai, S et al. (2000) Endocannabinoids as cardiovascular modulators. Chem Phys Lipids 108:159-68
|
|
Wagner, J A; Varga, K; Jarai, Z et al. (1999) Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension 33:429-34
|
|
Auer, K L; Spector, M S; Tombes, R M et al. (1998) Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway. FEBS Lett 436:131-8
|
|
Lake, K D; Martin, B R; Kunos, G et al. (1997) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29:1204-10
|
|
Lake, K D; Compton, D R; Varga, K et al. (1997) Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Ther 281:1030-7
|
|
Li, S J; Varga, K; Archer, P et al. (1996) Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci 16:5182-8
|
|
Ishac, E J; Jiang, L; Lake, K D et al. (1996) Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br J Pharmacol 118:2023-8
|
|
Varga, K; Lake, K D; Huangfu, D et al. (1996) Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28:682-6
|
Showing the most recent 10 out of 14 publications
